Targeted Drug ALK Inhibitors For NSCLC Report

By www.reportprimer.com

Report Details

Report Name

Global Targeted Drug ALK Inhibitors For NSCLC Market Size, Status And Forecast 2024-2031 Story

Pages

98

Price

$ 3900

Features

Targeted Drug ALK Inhibitors For NSCLC Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Pfizer
Novartis
Chugai Pharmaceutical (Hoffmann-La Roche group)
ARIAD Pharmaceuticals (Takeda)
Genvio Pharma Limited
Beacon Pharma Limited
Drug International Limted
Incepta Pharmaceuticals